EUVIMEDEUVIMED entdecken
Crossref

Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy

Jun-Long Liang, Xiao-Kang Jin, Shi-Man Zhang, Qian-Xiao Huang, Ping Ji, Xin-Chen Deng, Si-Xue Cheng, Wei-Hai Chen, Xian-Zheng Zhang

Science Bulletin · 2023-03 · 68 (6) · 622-636

DOI: 10.1016/j.scib.2023.02.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Bulletin, 2023-03. Verfasst von Jun-Long Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, China. Hauptthemen laut MEDLINE: Ferroptosis, Interferon Type I, Neoplasms. Die Arbeit wurde bisher 158-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activation of the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway could effectively initiate antitumor immunity, but specific activation of STING pathway is still an enormous challenge. Herein, a ferroptosis-induced mitochondrial DNA (mtDNA)-guided tumor immunotherapy nanoplatform (designated as HBMn-FA) was elaborately developed for activating and boosting STING-based immunotherapy. On the one hand, the high-levels of reactive oxygen species (ROS) in tumor cells induced by HBMn-FA-mediated ferroptosis elicited mitochondrial stress to cause the release of endogenous signaling mtDNA, which specifically initiate cGAS-STING pathway with the cooperation of Mn2+. On the other hand, the tumor-derived cytosolic double-stranded DNA (dsDNA) from debris of death cells caused by HBMn-FA further activated the cGAS-STING pathway in antigen-presenting cells (e.g., DCs). This bridging of ferroptosis and cGAS-STING pathway could expeditiously prime systemic antitumor immunity and enhance the therapeutic efficacy of checkpoint blockade to suppress tumor growth in both localized and metastatic tumor models. The designed nanotherapeutic platform paves the way for novel tumor immunotherapy strategies that are based on specific activation of STING pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisInterferon Type INeoplasmsHumansDNA, MitochondrialImmunotherapyNucleotidyltransferasesSTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Stichwörter der Autor:innen

FerroptosisNanotherapeuticsTumor immunotherapycGAS-STING pathwaymtDNA release

Substanzen

DNA, MitochondrialInterferon Type INucleotidyltransferasesSTING1 protein, humanSTING ProteincGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Autor:innen und Institutionen

  • Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, China.
  • Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, China; Cancer Precision Diagnosis and Treatment and Translational Medicine Hubei Engineering Rese…

Zitieren

APA

Liang, J. L., Jin, X. K., Zhang, S. M., Huang, Q. X., Ji, P., Deng, X. C., Cheng, S. X., Chen, W. H., & Zhang, X. Z. (2023). Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy. Science Bulletin, 68(6), 622-636. https://doi.org/10.1016/j.scib.2023.02.027

Vancouver

Liang JL, Jin XK, Zhang SM, Huang QX, Ji P, Deng XC, et al. Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy. Science Bulletin. 2023;68(6):622-636. doi:10.1016/j.scib.2023.02.027

BibTeX
@article{Liang2023,
  author = {Liang, Jun-Long and Jin, Xiao-Kang and Zhang, Shi-Man and Huang, Qian-Xiao and Ji, Ping and Deng, Xin-Chen and Cheng, Si-Xue and Chen, Wei-Hai and Zhang, Xian-Zheng},
  title = {Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy},
  journal = {Science Bulletin},
  year = {2023},
  volume = {68},
  number = {6},
  pages = {622--636},
  doi = {10.1016/j.scib.2023.02.027}
}
Kostenlos starten →